Recent studies have addressed a component of ADAMTS13:Ag in TTP prognosis during treatment and follow-up [11], linking five-fold higher mortality with ADAMTS13:Ag in the lowest quartile at diagnosis [12]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.